R J van de Stadt
Overview
Explore the profile of R J van de Stadt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
942
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Halm V, van Denderen J, Peters M, Twisk J, van der Paardt M, van der Horst-Bruinsma I, et al.
Ann Rheum Dis
. 2006 Apr;
65(11):1473-7.
PMID: 16644785
Background: Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possible explanation might be a more prevalent atherogenic lipid profile in patients with ankylosing spondylitis than in the general...
12.
Vis M, Havaardsholm E, Haugeberg G, Uhlig T, Voskuyl A, van de Stadt R, et al.
Ann Rheum Dis
. 2006 Apr;
65(11):1495-9.
PMID: 16606653
Objectives: To examine whether treatment with anti-tumour necrosis factor (TNF) alpha prevents loss of bone mineral density (BMD) at the spine and hip (generalised) and in the hands (local) of...
13.
Nielen M, van Schaardenburg D, Reesink H, Twisk J, van de Stadt R, van der Horst-Bruinsma I, et al.
Ann Rheum Dis
. 2005 Aug;
65(4):535-7.
PMID: 16079166
Objective: To investigate the temporal relationship between onset of inflammation (as measured by secretory phospholipase A2 (sPLA2) and C reactive protein (CRP)) and the presence of autoantibodies (IgM rheumatoid factor...
14.
van der Paardt M, Crusius J, de Koning M, Morre S, van de Stadt R, Dijkmans B, et al.
Ann Rheum Dis
. 2005 Jan;
64(2):235-8.
PMID: 15647432
Objectives: Ankylosing spondylitis (AS) is a multifactorial and polygenic disease. Apart from HLA, other genes very probably play a role in disease susceptibility. Indigenous bacteria of the gastrointestinal flora appear...
15.
Nielen M, van der Horst A, van Schaardenburg D, van der Horst-Bruinsma I, van de Stadt R, Aarden L, et al.
Ann Rheum Dis
. 2005 Jan;
64(8):1199-204.
PMID: 15640269
Background: The anti-cyclic citrullinated peptide (CCP) test has a high sensitivity and specificity for rheumatoid arthritis, although CCP is not the physiological target of the autoantibodies. Citrullinated fibrin is abundant...
16.
Vis M, Wolbink G, Lodder M, Kostense P, van de Stadt R, de Koning M, et al.
Arthritis Rheum
. 2003 Oct;
48(10):2996-7.
PMID: 14558111
No abstract available.
17.
Boers M, Nurmohamed M, Doelman C, Lard L, Verhoeven A, Voskuyl A, et al.
Ann Rheum Dis
. 2003 Aug;
62(9):842-5.
PMID: 12922956
Background: Glucocorticoids induce hypercholesterolaemia, a cardiovascular risk factor, in patients with diseases other than rheumatoid arthritis (RA), but the data in RA are contradictory. Objective: To determine the effects of...
18.
van der Paardt M, Crusius J, de Koning M, Murillo L, van de Stadt R, Dijkmans B, et al.
Genes Immun
. 2003 Feb;
4(1):77-8.
PMID: 12595906
An insertion mutation at nucleotide 3020 (3020insC) and a missense mutation G2722C in the CARD15 gene on chromosome 16p have been reported to be associated with Crohn's disease (CD). The...
19.
Bultink I, Lems W, van de Stadt R, Dinant H, Leyte A, Park D, et al.
Arthritis Rheum
. 2001 Apr;
44(4):979-81.
PMID: 11315939
No abstract available.
20.
Molenaar E, Lems W, Dijkmans B, De Koning M, van de Stadt R, Voskuyl A
Rheumatology (Oxford)
. 2000 Jul;
39(7):742-4.
PMID: 10908692
Objective: Clinical remission occurs in 10-20% of patients with rheumatoid arthritis (RA). However, it is questionable whether clinical remission corresponds to the complete absence of the inflammatory process. To answer...